UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in KRYS — Krystal Biotech, Inc.
CIK 861177
NEW YORK, NY
Position in KRYS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$14,382,512
+$4,840,950 QoQ
Shares Held
38,697
+4.8% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 419 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 45%
Shared 0%
None 55%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. KRYS ranks #33 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in KRYS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,382,512 | 38,697 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $9,541,562 | 36,937 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $8,287,932 | 33,617 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $35,763,033 | 202,589 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $32,209,623 | 234,320 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $103,763,727 | 575,506 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $32,930,242 | 210,202 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $40,946,735 | 224,945 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $46,233,571 | 251,762 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,249,177 | 18,261 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,534,048 | 20,426 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,369,416 | 20,426 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,971,496 | 16,793 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,344,446 | 16,793 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,225,612 | 15,471 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,127,187 | 16,172 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $998,490 | 15,207 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,011,872 | 15,207 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $712,999 | 10,193 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $454,487 | 8,705 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $591,940 | 8,705 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $721,633 | 9,367 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $640,020 | 10,667 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $459,213 | 10,667 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $223,668 | 5,400 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $253,688 | 5,867 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||